Kadans Science Partner

About Kadans Science Partner

Kadans Science Partner is a European developer, owner, and operator of specialised real estate for science and innovation. It focuses on creating bespoke environments for knowledge-intensive organisations in Life Sciences & Health, Agri & Food, Chemistry & Energy, and High Tech Systems & Materials.

The company positions itself as a partner in science rather than a traditional landlord. It invests in, develops, and operates lab-ready buildings and innovation hubs within science clusters, helping clients access the space, infrastructure, talent, research networks, and capital they need to grow.

Core Values

• Collaboration: Kadans emphasises bringing people together across science clusters so organisations can connect with researchers, entrepreneurs, universities, investors, and other innovators. Its model is built around proximity and ecosystem effects.
• Bespoke solutions: The company repeatedly stresses that there is no one-size-fits-all laboratory or innovation space. It works with clients through workshops and technical planning to configure facilities around specific research and operational needs.
• Innovation enablement: Kadans aims to create environments where scientific organisations can thrive and accelerate discovery, scale-up, and commercialisation. Its spaces are designed to support future growth and long-term innovation.
• Sustainability: Corporate responsibility content highlights energy efficiency, renewable energy use, waste reduction, and lower emissions in building design and operation. Kadans presents sustainability as part of how it develops responsible science environments.

Unique Aspects

• Backed by AXA IM Alts: Kadans has been backed by AXA IM Alts since 2020, giving it institutional support for continued expansion across Europe.
• Large European cluster network: The company says it operates across 30+ science clusters in six countries, giving clients access to a broad cross-border innovation network.
• Specialised asset focus: Unlike a conventional landlord, Kadans concentrates on science and technology real estate with lab-ready, cleanroom, pilot-plant, and flexible-lab formats built for research users.
• Scale and growth: Known news indicates that since the 2020 acquisition by AXA IM Alts, Kadans has expanded substantially, with its portfolio growing to more than 370,000 sqm of operating space and 230,000 sqm under development across 18 projects.
• European footprint: Kadans is present in the Netherlands, France, Germany, Belgium, Spain, and the UK/Ireland, and it uses that footprint to connect local science ecosystems with a wider European network.